Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06410833
What this trial is testing

Belimumab After Rituximab in Resistant Primary Juvenile SS

Who this might be right for
Sjogren's SyndromePediatric ALL
Peking Union Medical College Hospital 15
Early research (Phase 1)Study completedNCT02374333
What this trial is testing

Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy

Who this might be right for
Acute Lymphocytic LeukemiaDiffuse Large Cell Lymphoma
University of Pennsylvania 81
Not applicableNot Yet RecruitingNCT07162532
What this trial is testing

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Assiut University 45
Early research (Phase 1)Study completedNCT01991184
What this trial is testing

GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

Who this might be right for
Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma
Genentech, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT01397149
What this trial is testing

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Who this might be right for
Chronic Lymphocytic LeukemiaThrombocytopenia
University of Ulm 4
Testing effectiveness (Phase 2)UnknownNCT03262298
What this trial is testing

Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies

Who this might be right for
LeukemiaLymphoma
Affiliated Hospital to Academy of Military Medical Sciences 20
Not applicableActive Not RecruitingNCT06323447
What this trial is testing

Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

Who this might be right for
Diffuse Large B Cell LymphomaMultiple Myeloma
Leuko Labs, Inc. 210
Early research (Phase 1)WithdrawnNCT01490047
What this trial is testing

Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Solid TumorsLymphomas
Ludwig Institute for Cancer Research
Testing effectiveness (Phase 2)Study completedNCT00003849
What this trial is testing

Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 39
Not applicableUnknownNCT03380299
What this trial is testing

Association of CD49d and CD44 in CLL Patients and Their Role in Prognosis

Who this might be right for
Cellular Diagnosis, Chronic Lymphocytic Leukemia
Assiut University 2
Large-scale testing (Phase 3)Study completedNCT00033332
What this trial is testing

Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06508463
What this trial is testing

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise Specified+4 more
Mayo Clinic 21
Testing effectiveness (Phase 2)Study completedNCT01444716
What this trial is testing

Ofatumumab as Front-Line Therapy in Treating Elderly Participants With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00973752
What this trial is testing

Treatment of Older Adults With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Massachusetts General Hospital 30
Not applicableStudy completedNCT05230693
What this trial is testing

SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue

Who this might be right for
SarcoidosisFatigue
Medical University of South Carolina 50
Not applicableLooking for participantsNCT05283993
What this trial is testing

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+9 more
Peking University First Hospital 2,000
Testing effectiveness (Phase 2)UnknownNCT01678404
What this trial is testing

131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma

Who this might be right for
Relapsed or Refractory Marginal Zone B-cell Lymphoma
Korea Cancer Center Hospital 28
Not applicableLooking for participantsNCT04209244
What this trial is testing

Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Acute Lymphoblastic
Rigshospitalet, Denmark 100
Testing effectiveness (Phase 2)Study completedNCT00392834
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium 34
Testing effectiveness (Phase 2)Ended earlyNCT00437034
What this trial is testing

Aflibercept for Relapsed Multiple Myeloma

Who this might be right for
Stage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 6
Next Page